Matthew Wilson
Last active: 3/24/2020

piggyBac-ing models and new therapeutic strategies.

Woodard LE, Wilson MH
Trends Biotechnol. 2015 33 (9): 525-33

PMID: 26211958 · PMCID: PMC4663986 · DOI:10.1016/j.tibtech.2015.06.009

DNA transposons offer an efficient nonviral method of permanently modifying the genomes of mammalian cells. The piggyBac transposon system has proven effective in genomic engineering of mammalian cells for preclinical applications, including gene discovery, simultaneous multiplexed genome modification, animal transgenesis, gene transfer in vivo achieving long-term gene expression in animals, and the genetic modification of clinically relevant cell types, such as induced pluripotent stem cells and human T lymphocytes. piggyBac has many desirable features, including seamless excision of transposons from the genomic DNA and the potential to target integration events to desired DNA sequences. In this review, we explore these recent applications and also highlight the unique advantages of using piggyBac for developing new molecular therapeutic strategies.

Published by Elsevier Ltd.

MeSH Terms (7)

Animals Baculoviridae Genetic Engineering Genetic Vectors Genome Humans Mice

Connections (2)

This publication is referenced by other Labnodes entities: